Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients

被引：0
|
作者：
Meier-Stiegen, F. [1 ]
Schneck, H. [1 ]
Blassl, C. [1 ]
Neves, R. Pedro [2 ]
Janni, W. [3 ]
Fehm, T. [1 ]
Neubauer, H. [1 ]
机构：
[1] Univ Frauenklin Dusseldorf, Forschungslab Life Sci Ctr, Dusseldorf, Germany
[2] Univ Dusseldorf, Dusseldorf, Germany
[3] Univ Frauenklin Ulm, Ulm, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [1] Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients
    Schneck, Helen
    Blassl, Christina
    Meier-Stiegen, Franziska
    Neves, Rui Pedro
    Janni, Wolfgang
    Fehm, Tanja
    Neubauer, Hans
    MOLECULAR ONCOLOGY, 2013, 7 (05) : 976 - 986
  • [2] Mutational Status of PIK3CA in Circulating Tumor Cells of Metastatic Breast Cancer Patients on Single Cell Level
    Schoemer, S.
    Meier-Stiegen, F.
    Andre, F.
    Neubauer, H.
    Janni, W.
    Wallwiener, D.
    Fehm, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 178 - 178
  • [3] Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
    Pestrin, Marta
    Salvianti, Francesca
    Galardi, Francesca
    De Luca, Francesca
    Turner, Natalie
    Malorni, Luca
    Pazzagli, Mario
    Di Leo, Angelo
    Pinzani, Pamela
    MOLECULAR ONCOLOGY, 2015, 9 (04) : 749 - 757
  • [4] PIK3CA mutational status in circulating tumor cells (CTCs) and corresponding circulating tumor DNA in breast cancer patients
    Tzanikou, Elena
    Markou, Athina
    Malamos, Nikos
    Georgoulias, Vasilis
    Lianidou, Evi S.
    CANCER RESEARCH, 2016, 76
  • [5] PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer
    Markou, Athina
    Farkona, Sofia
    Schiza, Christina
    Efstathiou, Tonia
    Kounelis, Sophia
    Malamos, Nikos
    Georgoulias, Vassilis
    Lianidou, Evi
    CLINICAL CANCER RESEARCH, 2014, 20 (22) : 5823 - 5834
  • [6] Prognostic role of PIK3CA mutational status in circulating tumor DNA (ctDNA) from HER2-positive metastatic breast cancer patients
    Lim, J.
    Lee, K-H
    Min, A.
    Kim, S-G
    Kim, J-E
    Kim, T-Y
    Han, S-W
    Oh, D-Y
    Kim, T-Y
    Lim, S-A
    CANCER RESEARCH, 2017, 77
  • [7] PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer
    Marino, Elena
    Mauro, Cristian
    Belloni, Elena
    Picozzi, Marco
    Favalli, Valentina
    Cassatella, Maria Cristina
    Zorzino, Laura
    Giaco, Luciano
    Pelicci, Pier Giuseppe
    Barberis, Massimo
    Sandri, Maria Teresa
    Bernard, Loris
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 39
  • [8] Characterization of Circulating Tumor Cells regarding Mutational Status of PIK3CA and Expression of Androgen Receptor
    Meier-Stiegen, E.
    Neubacher, M.
    Schoemer, S.
    Krawczyk, N.
    Neubauer, H.
    Niederacher, D.
    Janni, W.
    Fehm, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 55 - 55
  • [9] PIK3CA MUTATIONS AND LOSS OF PTEN EXPRESSION IN CIRCULATING TUMOR CELLS (CTCS) IN PATIENTS WITH METASTATIC BREAST CANCER (MBC)
    Lozano Mejorada, R.
    Matos, I.
    Marcos, R. A.
    Alfonso, S.
    Guillen, C.
    Noguerido, A.
    Rua, O.
    Vidal, R.
    Hernandez, M. A.
    Garcia, J. L.
    Gomez Bernal, A.
    Rodriguez, C. A.
    Cruz Hernandez, J. J.
    ANNALS OF ONCOLOGY, 2014, 25
  • [10] ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study
    Takeshita, Takashi
    Yamamoto, Yutaka
    Yamamoto-Ibusuki, Mutsuko
    Tomiguchi, Mai
    Sueta, Aiko
    Iwase, Hirotaka
    CANCER BIOMARKERS, 2018, 22 (02) : 345 - 350
12345